 Home > Medical News > Latest Medical News > Gale announced that the Phase II clinical trial application of ASC22 (envolimab) for immune reconstitution/functional cure of human immunodeficiency virus type 1 (HIV-1) infected persons has been approved by the State Food and Drug Administration of China

Gale announced that the Phase II clinical trial application of ASC22 (envolimab) for immune reconstitution/functional cure of human immunodeficiency virus type 1 (HIV-1) infected persons has been approved by the State Food and Drug Administration of China

 Last Update: 2021-12-08
 Source: Internet
 Author: User

Tags

thyroid peroxidase antibodies

all chinese show

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Hangzhou and Shaoxing, China, November 10, 2021/PRNewswire/ - Golly Pharmaceuticals Co.

ASC22 (Envolimab) is a subcutaneously injected PD-L1 single domain antibody, which has the potential to rebuild the virus-specific immune response of patients with chronic viral infection

It is estimated that there are about 38 million people living with AIDS in the world, and about 690,000 people died of AIDS in 2019, and there are about 1.

The Phase II trial is a randomized, single-blind, placebo-controlled, multi-center Chinese clinical trial that evaluates 1 mg/kg, 2.

"Compared with healthy subjects, the expression of PD-1/PD-L1 in people infected with HIV-1 is increased

About songli

Gale is an innovative R&D-driven biotechnology company listed on the Hong Kong Stock Exchange (1672.

Source: Golly Pharmaceutical Co.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.